Become part of MedCap
Investors & Media
sv
About us
Strategy
Become part of MedCap
Board of Directors
Management Team
Transaction History
Objectives
Business Areas
Assistive Tech
Abilia
Trident
Huka
Erimed
Danrehab
Swedelift
Specialty Pharma
Unimedic
XGX Pharma AS
MedTech
Cardiolex
Inpac
Multi-ply
SurgiCube
Toul Meditech
Investors & Media
The Share
Share capital
Shareholder Structure
Insider Trading
Analysts
Financial reports and presentations
Other presentations
Prospectus
Calendar
Offer to shareholders in AdderaCare
Press and media
Press releases
Request Information
Images
Corporate Governance
Articles of Association
General Meeting
Nomination Committee
Internal Controls
Board
Board Duties
Board Committees
Board Remuneration
Management
Management Remuneration
Auditors
Sustainability
Our long-term sustainability focus
Our Focus Areas
Our contribution to the UN’s Global Goals
Whistleblower function
Contact
Press releases
All press releases
Regulatory
Annual report
Interim report
All years
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
7/24/2023 2:30 PM
MedCap acquires SurgiCube and Toul Meditech
Regulatory
Read more
5/3/2023 6:30 AM
Strong growth in the first quarter – adjusted EBITDA up 33 percent
Regulatory
Interim report
Read more
2/10/2023 6:30 AM
Strong organic growth in both the quarter and the year
Regulatory
Interim report
Read more
1/10/2023 2:30 PM
MedCap AB (publ) announces the final outcome in its recommended cash offer to the shareholders of AdderaCare
Regulatory
Read more
12/27/2022 2:30 PM
MedCap announces the final outcome in its recommended cash offer to the shareholders of AdderaCare
Regulatory
Read more
12/23/2022 8:00 PM
MedCap completes the recommended cash offer to the shareholders of AdderaCare and extends the acceptance period
Regulatory
Read more
12/1/2022 8:30 AM
Offer document regarding the offer to the shareholders of AdderaCare made public
Regulatory
Read more
11/17/2022 7:45 AM
MedCap AB (publ) announces a recommended cash offer at a price of SEK 3.60 per share to the shareholders of AdderaCare AB (publ)
Regulatory
Read more
10/28/2022 6:30 AM
Sales and earnings growth – EBITDA increased by 32%
Regulatory
Interim report
Read more
7/29/2022 6:30 AM
A strong quarter throughout the Group - EBITDA increased by 29 percent
Regulatory
Interim report
Read more
1
2
3
4
